Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, cheese, and fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.
Evrofarma Dividend Announcement
• Evrofarma announced a annually dividend of €0.05 per ordinary share which will be made payable on 2024-09-19. Ex dividend date: 2024-09-12
• Evrofarma annual dividend for 2024 was €0.05
• Evrofarma's trailing twelve-month (TTM) dividend yield is 3.23%
Evrofarma Dividend History
| Ex-Div date | Dividend amount | Dividend type | Pay date |
|---|---|---|---|
| 2024-09-12 | €0.05 | annually | 2024-09-19 |
| 2008-07-18 | €0.01 | annually | |
| 2006-07-24 | €0.02 | annually | |
| 2005-06-16 | €0.04 | annually | |
| 2004-04-30 | €0.04 | annually | |
| 2003-06-26 | €0.03 | annually | |
| 2002-06-25 | €0.03 | annually | |
| 2001-06-20 | €0.09 | annually |
Evrofarma Dividend per year
Evrofarma Dividend growth
Evrofarma Dividend Yield
Evrofarma current trailing twelve-month (TTM) dividend yield is 3.23%. Interested in purchasing Evrofarma stock? Use our calculator to estimate your expected dividend yield:
Evrofarma Financial Ratios
P/E ratio14.19
PEG ratio1.40
P/B ratio1.31
ROE9.36%
Payout ratio0.00%
Current ratio1.25
Quick ratio0.75
Cash Ratio0.05
Evrofarma Dividend FAQ
Does Evrofarma stock pay dividends?
Evrofarma does not currently pay dividends to its shareholders.
Has Evrofarma ever paid a dividend?
No, Evrofarma has no a history of paying dividends to its shareholders. Evrofarma is not known for its dividend payments.
Why doesn't Evrofarma pay dividends?
There are several potential reasons why Evrofarma would choose not to pay dividends to their shareholders:
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Evrofarma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Evrofarma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Evrofarma a dividend aristocrat?
Evrofarma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Evrofarma a dividend king?
Evrofarma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Evrofarma a dividend stock?
No, Evrofarma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Evrofarma stocks?
To buy Evrofarma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.
Place an order: Use the brokerage's trading platform to place an order to buy Evrofarma stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
Place an order: Use the brokerage's trading platform to place an order to buy Evrofarma stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.